ArticlePloS one2019
What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India.
Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 23 citations in OpenAlex.
- Impact and Economic Evaluation of the Patient-Provider Support Agency Model Under India's National Tuberculosis Elimination Program: Protocol for a Cohort Study.JMIR research protocols · 2026Article
- Engaging private providers to enhance tuberculosis detection and notification: evidence from TB REACH-Supported projects.BMC public health · 2025Article
- Policy gaps in addressing market failures and intervention misalignments in tuberculosis control: prospects for improvement in China, India, and Indonesia.The Lancet regional health. Western Pacific · 2024Review
- Operational priorities for engaging with India's private healthcare sector for the control of tuberculosis: a modelling study.BMJ open · 2024Article
- Participation of private providers in the National TB Programme in South India.Public health action · 2023Article
- Pharmacy engagement in TB prevention and care: not if, but how?BMJ global health · 2023Article
- Engaging the Private Health Service Delivery Sector for TB Care in India-Miles to Go!Tropical medicine and infectious disease · 2023Review
- Integrating private health facilities in government-led health systems: a case study of the public-private mix approach in Ethiopia.BMC health services research · 2022Article
- The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India.BMC infectious diseases · 2022Article
- STEPS - a patient centric and low-cost solution to ensure standards of TB care to patients reaching private sector in India.BMC health services research · 2022Article
- Activity-based costing for HIV, primary care and nutrition services in low- and middle-income countries: A systematic literature review and synthesis.Journal of global health economics and policy · 2021Article
- TB notification rates across parliamentary constituencies in India: a step towards data-driven political engagement.Tropical medicine & international health : TM & IH · 2021Article
- Engaging Informal Private Health Care Providers for TB Case Detection: Experiences from RIPEND Project in India.Tuberculosis research and treatment · 2021Article
- Enhanced Private Sector Engagement for Tuberculosis Diagnosis and Reporting through an Intermediary Agency in Ho Chi Minh City, Viet Nam.Tropical medicine and infectious disease · 2020Article
- Leveraging Providers' Preferences to Customize Instructional Content in Information and Communications Technology-Based Training Interventions: Retrospective Analysis of a Mobile Phone-Based Intervention in India.JMIR mHealth and uHealth · 2020Article
- Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh.PloS one · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 7 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrivate providers dominate health care in India and provide most tuberculosis (TB) care. Yet efforts to engage private providers were viewed as unsustainably expensive. Three private provider engagement pilots were implemented in Patna, Mumbai and Mehsana in 2014 based on the recommendations in the National Strategic Plan for TB Control, 2012-17. These pilots sought to improve diagnosis and treatment of TB and increase case notifications by offering free drugs and diagnostics for patients who sought care among private providers, and monetary incentives for providers in one of the pilots. As these pilots demonstrated much higher levels of effectiveness than previously documented, we sought to understand program implementation costs and predict costs for their national scale-up. METHODS AND
findingsWe developed a common cost structure across these three pilots comprising fixed and variable cost components. We conducted a retrospective, activity-based costing analysis using programmatic data and qualitative interviews with the respective program managers. We estimated the average recurring costs per TB case at different levels of program scale for the three pilots. We used these cost estimates to calculate the budget required for a national scale up of such pilots. The average cost per privately-notified TB case for Patna, Mumbai and Mehsana was estimated to be US$95, US$110 and US$50, respectively, in May 2016 when these pilots were estimated to cover 50%, 36% and 100% of the total private TB patients, respectively. For Patna and Mumbai pilots, the average cost per case at full scale, i.e. 100% coverage of private TB patients, was projected to be US$91 and US$101, respectively. In comparison, the national TB program's budget for 2015 averages out to $150 per notified TB case. The total annual additional budget for a national scale up of these pilots was estimated to be US$267 million.
conclusionsAs India seeks to eliminate TB, extensive national engagement of private providers will be required. The cost per privately-notified TB case from these pilots is comparable to that already being spent by the public sector and to the projected cost per privately-notified TB case required to achieve national scale-up of these pilots. With additional funds expected to execute against national TB elimination commitments, the scale-up costs of these operationally viable and effective private provider engagement pilots are likely to be financially viable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.